Abstract
Major controversy exists about whether to treat patients with ST-segment elevation myocardial infarction using fibrinolysis or percutaneous intervention. A study of 1,492 patients from approximately 60% of French hospitals demonstrates that similarly excellent 5-year outcomes can be achieved with either reperfusion strategy. Therefore, one size need not necessarily fit all.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
